These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2432855)

  • 1. Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Le Long
    Arch Virol; 1987; 92(1-2):55-62. PubMed ID: 2432855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of antigenic variants of Newcastle disease virus Italian strain selected with monoclonal antibodies.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Long LE
    Ann Rech Vet; 1987; 18(4):371-4. PubMed ID: 2454065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of reference strains of Newcastle disease virus (NDV) and NDV-like isolates by monoclonal antibodies to HN subunits.
    Ishida M; Nerome K; Matsumoto M; Mikami T; Oya A
    Arch Virol; 1985; 85(1-2):109-21. PubMed ID: 2409954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria.
    Iorio RM; Lawton KA; Nicholson PM; Bratt MA
    Virus Res; 1984 Oct; 1(7):513-25. PubMed ID: 6085438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.
    Iorio RM; Glickman RL; Riel AM; Sheehan JP; Bratt MA
    Virus Res; 1989 Jul; 13(3):245-61. PubMed ID: 2475989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
    Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
    Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; McCartney H; Meulemans G; Alexander DJ; Collins MS; Emmerson PT; Samson AC
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():3105-9. PubMed ID: 2479718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons.
    Nishikawa K; Isomura S; Suzuki S; Watanabe E; Hamaguchi M; Yoshida T; Nagai Y
    Virology; 1983 Oct; 130(2):318-30. PubMed ID: 6196907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.
    Neyt C; Geliebter J; Slaoui M; Morales D; Meulemans G; Burny A
    J Virol; 1989 Feb; 63(2):952-4. PubMed ID: 2463386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage.
    Umino Y; Kohama T; Sato TA; Sugiura A; Klenk HD; Rott R
    J Gen Virol; 1990 May; 71 ( Pt 5)():1189-97. PubMed ID: 1693166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies.
    Abenes G; Kida H; Yanagawa R
    Arch Virol; 1986; 90(1-2):97-110. PubMed ID: 2425781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.
    Ray R; Compans RW
    Virology; 1986 Jan; 148(1):232-6. PubMed ID: 2417412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus.
    Samson AC; Russell PH; Hallam SE
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():357-61. PubMed ID: 3838186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants.
    Russell PH
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():795-8. PubMed ID: 6546769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative investigation of monoclonal and polyclonal antibodies directed against strain-specific and common antigenic sites on influenza H1N1 virus hemagglutinin.
    Drescher J; Verhagen W; Flik J; Stachan R
    Intervirology; 1987; 27(4):205-17. PubMed ID: 2447032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.
    Tsurudome M; Nishio M; Komada H; Bando H; Ito Y
    Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus.
    Hummel KB; Bellini WJ
    J Virol; 1995 Mar; 69(3):1913-6. PubMed ID: 7853533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
    Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
    Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies.
    Hodder AN; Selleck PW; White JR; Gorman JJ
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1081-91. PubMed ID: 8509761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.